Sysmex Corporation
General ticker "SSMXF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $6.9B (TTM average)
Sysmex Corporation does not follow the US Stock Market performance with the rate: -33.6%.
Estimated limits based on current volatility of 0.0%: low 9.65$, high 9.65$
Factors to consider:
- Earnings expected soon, date: nan
- Company pays dividends (annually): last record date 2026-03-31, amount 0.12$ (Y1.24%)
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [13.69$, 22.30$]
- 2026-03-31 to 2027-03-31 estimated range: [14.43$, 23.30$]
Financial Metrics affecting the SSMXF estimates:
- Positive: with PPE of 34.8 at the end of fiscal year the price was neutral
- Positive: 7.78 < Operating profit margin, % of 17.22
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.47 > 6.08
- Negative: Industry inventory ratio change (median), % of 1.72 > 0.27
- Positive: -4.44 < Investing cash flow per share per price, % of -2.89
- Negative: 0.01 < Interest expense per share per price, % of 0.19
- Positive: Inventory ratio change, % of -0.80 <= -0.76
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of 1.23 <= 5.54
Short-term SSMXF quotes
Long-term SSMXF plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥410,502.00MM | ¥461,510.00MM | ¥508,643.00MM |
| Operating Expenses | ¥337,851.00MM | ¥384,213.00MM | ¥421,060.00MM |
| Operating Income | ¥72,651.00MM | ¥77,297.00MM | ¥87,583.00MM |
| Non-Operating Income | ¥-3,938.00MM | ¥-2,697.00MM | ¥-8,362.00MM |
| Interest Expense | ¥1,566.00MM | ¥2,386.00MM | ¥3,518.00MM |
| R&D Expense | ¥31,060.00MM | ¥31,402.00MM | ¥31,455.00MM |
| Income(Loss) | ¥68,713.00MM | ¥74,600.00MM | ¥79,221.00MM |
| Taxes | ¥22,988.00MM | ¥24,826.00MM | ¥25,645.00MM |
| Net Income(Loss)* | ¥45,784.00MM | ¥49,639.00MM | ¥53,669.00MM |
| Stockholders Equity | ¥387,665.00MM | ¥432,045.00MM | ¥463,776.00MM |
| Inventory | ¥73,310.00MM | ¥79,123.00MM | ¥81,811.00MM |
| Assets | ¥531,073.00MM | ¥618,917.00MM | ¥665,268.00MM |
| Operating Cash Flow | ¥68,835.00MM | ¥63,905.00MM | ¥88,246.00MM |
| Capital expenditure | ¥42,505.00MM | ¥50,191.00MM | ¥49,959.00MM |
| Investing Cash Flow | ¥-51,751.00MM | ¥-54,970.00MM | ¥-52,488.00MM |
| Financing Cash Flow | ¥-24,234.00MM | ¥-9,013.00MM | ¥-24,322.00MM |
| Earnings Per Share** | ¥72.94 | ¥79.27 | ¥86.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.